Estrogen management in men on testosterone therapy is one of the most clinically nuanced areas of hormone optimization practice — and one of the most frequently mishandled. Overtreatment of estrogen is at least as problematic as undertreatment, and the “keep estrogen as low as possible” approach that was common in earlier TRT practice has been substantially refined by the evidence base. Here is the current clinical framework.
Testosterone aromatizes to estradiol in peripheral tissues — particularly adipose tissue — through the aromatase enzyme. This conversion is physiologically normal and necessary: men require estradiol for bone density, cardiovascular health, cognitive function, libido, and mood. The clinical concern is excessive aromatization — which occurs when testosterone doses are too high, when aromatase activity is elevated (often in the context of higher body fat percentage), or in individual patients with high aromatase sensitivity — producing supraphysiological estradiol levels that cause symptoms of estrogen excess: water retention, mood instability, gynecomastia, and libido reduction.
The clinical decision to use an aromatase inhibitor (AI) — most commonly anastrozole or exemestane — should be based on symptomatic assessment in context of laboratory values, not on laboratory values alone. Men with estradiol in the 40–60 pg/mL range who are asymptomatic often do not require AI treatment. Men with estradiol in the same range who are symptomatic (breast tenderness, water retention, mood changes) may benefit from a low-dose AI. Men with estradiol below 20 pg/mL should never be on an AI — low estradiol in men is associated with bone loss, sexual dysfunction, and cardiovascular risk.
The dose and frequency of anastrozole requires careful titration — the standard 0.5mg twice weekly used in many TRT clinics is frequently too aggressive. Starting at 0.25mg one to two times weekly and titrating based on labs and symptoms produces better outcomes with less risk of over-suppression. Some patients are extremely sensitive to anastrozole and do better with exemestane, which is a steroidal AI with a different mechanistic profile. Book your Practitioner Training session here. Call 844-734-2112.